EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nasal Administration of Lipopolysaccharide Exacerbates Allergic Rhinitis through Th2 Cytokine Production from Mast Cells

Noriaki Aoi, Takafumi Fuchiwaki, Ichiro Morikura, Hideyuki Kawauchi, Tatsunori Sakamoto

Allergies · 2021

DOI: 10.3390/allergies1040020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergies, 2021. Verfasst von Noriaki Aoi und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microbial infection or exposure to endotoxin later in life exacerbates established asthma. Mast cells are involved in the exacerbation of asthma. This exacerbation involves a toll-like receptor (TLR)–mediated response of mast cells. In the clinical practice of otolaryngology, otolaryngologists experience an exacerbation of nasal congestion when infectious rhinitis develops in patients with allergic rhinitis, but the mechanisms are unknown. Therefore, this study investigated the effect of lipopolysaccharide (LPS) on allergic rhinitis using a mouse allergic rhinitis model.

Methods

Female BALB/c mice, TLR4 gene mutant C3H/HeJ mice or mast cell–deficient WBB6F1-W/Wv mice were sensitized intraperitoneally with ovalbumin (OVA)/alum, and were intranasal challenged with OVA and/or LPS. Nasal symptoms and histologic changes were examined. Cytokines in nasal tissue were examined by Western blot. The effects of LPS on degranulation and cytokine production of bone marrow–derived mast cells (BMMCs) were investigated.

Results

Nasal administration of LPS together with the antigen exacerbated nasal symptoms, eosinophil infiltration of the nasal mucosa, and increased IL-5 production in the nasal mucosa. It was not observed in C3H/HeJ mice and WBB6F1-W/Wv mice. The addition of LPS increased the production of IL-5 from BMMCs in a dose-dependent manner, but no effect on degranulation was observed.

Conclusions

Intranasal administration of LPS exacerbates allergic rhinitis through Th2 cytokine production from mast cells. This observation provides clues to the mechanism of exacerbation of allergic rhinitis caused by an infection in daily clinical practice.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Aoi, N., Fuchiwaki, T., Morikura, I., Kawauchi, H., & Sakamoto, T. (2021). Nasal Administration of Lipopolysaccharide Exacerbates Allergic Rhinitis through Th2 Cytokine Production from Mast Cells. Allergies. https://doi.org/10.3390/allergies1040020

Vancouver

Aoi N, Fuchiwaki T, Morikura I, Kawauchi H, Sakamoto T. Nasal Administration of Lipopolysaccharide Exacerbates Allergic Rhinitis through Th2 Cytokine Production from Mast Cells. Allergies. 2021. doi:10.3390/allergies1040020

BibTeX
@article{Aoi2021,
  author = {Aoi, Noriaki and Fuchiwaki, Takafumi and Morikura, Ichiro and Kawauchi, Hideyuki and Sakamoto, Tatsunori},
  title = {Nasal Administration of Lipopolysaccharide Exacerbates Allergic Rhinitis through Th2 Cytokine Production from Mast Cells},
  journal = {Allergies},
  year = {2021},
  doi = {10.3390/allergies1040020}
}
Kostenlos starten →